Dennis van Hamont

Dr. Dennis van Hamont

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
CRCasper Reijnen
Casper Reijnen
NVNicole Cm Visser
Nicole Cm Visser
JKJenneke C Kasius
Jenneke C Kasius
DBDorry Boll
Dorry Boll
PGPeggy M Geomini
Peggy M Geomini
JPJohanna Pijnenborg
Johanna Pijnenborg
Reijnen C, et al. J Gynecol Oncol. 2018 Aug;30:e70. https://doi.org/10.3802/jgo.2019.30.e70

4 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MLMarike S. Lombaers
Marike S. Lombaers
KCKarlijn Maria Cornelia Cornel
Karlijn Maria Cornelia Cornel
NVNicole C. M. Visser
Nicole C. M. Visser
JBJohan Bulten
Johan Bulten
HKHeidi V. N. Küsters-Vandevelde
Heidi V. N. Küsters-Vandevelde
JPJohanna Pijnenborg
Johanna Pijnenborg
Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on cancer antigen 125 (CA125) in high-grade EC are limited, we aimed to study primarily the predictive value of CA125, and secondarily the contributive value of computed tomography (CT) for advanced stage and LNM. Patients with high-grade EC (n = 333) and available preoperative CA125 were included retrospectively. The association of CA125 and CT findings with LNM was analyzed by logistic regression. Elevated CA125 ((>35 U/mL), (35.2% (68/193)) was significantly associated with stage III-IV disease (60.3% (41/68)) compared with normal CA125 (20.8% (26/125), [p < 0.001]), and with reduced disease-specific—(DSS) (p < 0.001) and overall survival (OS) (p < 0.001). The overall accuracy of predicting LNM by CT resulted in an area under the curve (AUC) of 0.623 (p < 0.001) independent of CA125. Stratification by CA125 resulted in an AUC of 0.484 (normal), and 0.660 (elevated). In multivariate analysis elevated CA125, non-endometrioid histology, pathological deep myometrial invasion ≥50%, and cervical involvement were significant predictors of LNM, whereas suspected LNM on CT was not. This shows that elevated CA125 is a relevant independent predictor of advanced stage and outcome specifically in high-grade EC.

31 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
KKKim van Kol
Kim van Kol
RERenée Ebisch
Renée Ebisch
MBMaaike Beugeling
Maaike Beugeling
JCJeltsje Cnossen
Jeltsje Cnossen
JNJ. (Joost) Nederend
J. (Joost) Nederend
Ruud BekkersRuud Bekkers
Ruud Bekkers
Objectives: There is no consensus on the most reliable procedure to determine remission of cervical cancer after chemoradiotherapy (CRT). Therefore, this study aims to assess the diagnostic performance of two different imaging techniques, MRI and 18F[FDG]-PET/CT, in determining the presence of locoregional residual disease after CRT in patients with locally advanced cervical cancer. Methods: Patients diagnosed with locally advanced cervical cancer (FIGO 2009) treated with CRT were retrospectively identified from a regional cohort. The accuracy of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was assessed with histology as the reference standard. Results: The negative predictive value (NPV) and positive predictive value (PPV) for locoregional residual disease detection of MRI and 18F[FDG]-PET/CT combined were 84.2% (95% CI 73.2–92.1), and 70.4% (95% CI 51.8–85.2), respectively. The NPV and PPV of MRI alone were 80.2% (95% CI 71.2–87.5) and 47.7% (95% CI 35.8–59.7), respectively, and values of 81.1% (95% CI 72.2–88.3) and 55.8 (95% CI 42.2–68.7), respectively, were obtained for 18F[FDG]-PET/CT alone. Conclusion: In this study, the reliability of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was limited. Combining MRI and 18F[FDG]-PET/CT did not improve predictive values. Routine use of both MRI and 18F[FDG]-PET/CT in the follow-up after CRT should be avoided. MRI during follow-up is the advised imaging technique. Pathology confirmation of the presence of locoregional residual disease before performing salvage surgery is warranted.

1 October 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
WRWinesh Ramphal
Winesh Ramphal
CPChloé M L Peters
Chloé M L Peters
LALuthy S M Alcalá
Luthy S M Alcalá
DHDennis van Hamont
Dennis van Hamont
PGPaul D Gobardhan
Paul D Gobardhan
Adenomyomas are benign tumours made of smooth muscle cells, endometrial glands and stroma. An extrauterine location is extremely rare with an unknown pathogenesis. Preoperative diagnosis is challenging and pathologic examination is necessary to confirm the diagnosis. Here we present a case report of a 44-year-old woman with a painful non-reducible mass in the right inguinal region without fever or other alarming symptoms 2 months after a laparoscopic hysterectomy. She was treated with a surgical resection of the mass. Extrauterine adenomyoma is a very uncommon entity. Preoperative workup is challenging, as confirmation of the diagnosis can only be achieved by histopathological analysis following surgical excision.

20 January 2023 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
MFMinke Frijstein
Minke Frijstein
LBLaura Blok
Laura Blok
MKMarianne Ten Kate-Booij
Marianne Ten Kate-Booij
YEYalck Eysbouts
Yalck Eysbouts
NTNienke van Trommel
Nienke van Trommel
OGon behalf of the Trophy Study Group
on behalf of the Trophy Study Group
Objective: Gestational trophoblastic diseases (GTD) comprise a group of rare diseases originating from the trophoblast affecting women of childbearing age. Providing optimal information to patients with a rare disease is challenging because of the small number of patients and limited clinical expertise of many healthcare professionals. Both knowledge and lack of knowledge in patients may influence illness perception. We investigated whether a web-based interactive intervention influences illness perception and knowledge in women with GTD. Design: This was a multicenter randomized control trial conducted at general and academic hospitals in the Netherlands, including newly diagnosed GTD patients between 2017 and 2019. Methods: Sixty-nine patients were randomized between direct access or postponed access to an online tool on GTD and received online questionnaires about illness perception, knowledge, and anxiety. The main outcome measures were illness perception (primary outcome measure) and knowledge (secondary outcome measure). Results: Patients using the online tool were satisfied with the information from the tool (92%). Although they had a higher level of knowledge compared to the control group (p = 0.006), illness perception did not change. Also, no differences in levels of anxiety, depression, or distress were observed between the groups. Limitations: Participants had access to other information sources and many searched other websites. It is unknown what kind of websites were visited and when. It is unknown if the increased knowledge levels and low levels of distress will sustain over time as no long term follow-up took place. Healthcare professionals were not interviewed on how they experienced the consultation before and after using the tool by the patients. Conclusions: The online tool did not change illness perception but was shown to be valuable for newly diagnosed GTD patients to gain knowledge. The improvement in knowledge after digital education indicates that this tool can be used as an effective method of supporting GTD patients’ informational needs without causing extra distress. Tweetable A web-based tool for trophoblastic disease does not change illness perception of patients but is valuable to gain knowledge.

18 November 2026 in eClinicalMedicine
Verified
Journal Article
Open access
LKLieke van de Kam
Lieke van de Kam
VCVéronique van Cooten
Véronique van Cooten
EPEva Piera
Eva Piera
ASAlbert G Siebers
Albert G Siebers
MLMarleen de Leeuw
Marleen de Leeuw
Jurgen PiekJurgen Piek
Jurgen Piek